Price Alert

Hepion Pharmaceuticals In... (HEPA)

NASDAQ: HEPA · Real-Time Price · USD

0.07

0.01 (22.59%)

At close: Jun 09, 2025, 3:45 PM

Hepion Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	406.41K	1.5M	2.12M	13.11M	14.79M	19.28M	30.52M	42.99M	51.19M	59.15M	71.71M	79.22M	91.35M	98.73M	110.09M	115.45M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-564.84K	n/a	n/a	n/a	-619.38K	n/a	n/a	n/a
Other Long-Term Assets	n/a	66.5K	377.02K	377.02K	301.71K	260.08K	488.88K	436.1K	426.17K	654.52K	567.54K	652.18K	-36.06K	495.18K	420.02K	285.1K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	600K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	1.61M	3.53M	5.48M	15.43M	17.49M	21.27M	32.76M	45.81M	56.5M	65.67M	79.53M	89.77M	97.45M	105.5M	113.67M	117.74M
Property-Plant & Equipment	n/a	118.3K	150.73K	182.02K	242.37K	283.59K	60.77K	63.75K	132.21K	183.23K	274.81K	367.52K	456.46K	545.35K	599.15K	666.12K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	3.19M	3.19M	3.19M	3.19M	3.19M	3.19M	5.06M	5.06M	5.06M	5.06M	5.06M
Total Long-Term Assets	n/a	184.81K	527.75K	559.04K	606.56K	3.73M	3.74M	3.69M	3.75M	4.03M	4.03M	6.08M	6.1M	6.1M	6.08M	6.01M
Total Assets	1.61M	3.72M	6.01M	15.99M	18.09M	25M	36.5M	49.5M	60.24M	69.7M	83.57M	95.86M	103.55M	111.6M	119.75M	123.76M
Account Payables	220.2K	186.26K	446.54K	1.5M	2.35M	3.01M	4.19M	3.17M	2.67M	2.63M	8.91M	2.38M	2.45M	1.79M	3.09M	1.66M
Deferred Revenue	n/a	n/a	n/a	n/a	2.44M	2.91M	n/a	n/a	4.8M	n/a	n/a	n/a	2.51M	2.21M	1.67M	n/a
Short-Term Debt	2.9M	2.22M	154.09K	n/a	115.92K	n/a	n/a	n/a	53.61K	105.58K	176.86K	247.34K	266.65K	285.28K	286.02K	387.73K
Other Current Liabilities	n/a	188.05K	-154.09K	149K	270.08K	376.43K	2.76M	6.27M	2.22M	3.8M	3.6M	3.16M	4.36M	3.37M	2.36M	299.65K
Total Current Liabilities	3.14M	2.72M	975.63K	2.57M	5.29M	6.4M	7.67M	9.8M	7.89M	7.49M	13.38M	6.26M	8.21M	7.08M	7.1M	2.87M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	333.19K	1.41M	1.47M	5.85M	5.43M	1.9M	2.05M	2.13M	2.09M	2.54M	2.46M	2.55M	1.89M	1.37M	1.35M	2.61M
Total Long-Term Liabilities	333.19K	1.41M	1.47M	5.89M	5.52M	2.44M	2.46M	2.54M	2.5M	2.95M	2.87M	2.96M	2.35M	1.88M	1.93M	3.31M
Total Liabilities	3.48M	4.12M	2.45M	8.47M	10.81M	8.84M	10.13M	12.34M	10.39M	10.44M	16.25M	9.22M	10.56M	8.96M	9.03M	6.18M
Total Debt	2.9M	2.22M	154.09K	175.27K	209.02K	241.54K	n/a	n/a	53.61K	105.58K	176.86K	247.34K	316.99K	384.42K	452.87K	688.11K
Common Stock	14.00	663.00	547.00	547.00	482.00	384.00	384.00	381.00	7.62K	7.62K	7.62K	7.62K	7.62K	7.62K	7.62K	7.62K
Retained Earnings	-237.82M	-236.27M	-231.41M	-227.48M	-224.63M	-213.57M	-203.04M	-188.96M	-175.7M	-168.89M	-160.34M	-140.43M	-133.5M	-127.09M	-117.83M	-110.16M
Comprehensive Income	8.35K	-53.83K	-53.82K	9.2K	-78.78K	-93.93K	-87.65K	-70.81K	-90.17K	-90.33K	-29.97K	9.15K	0.00	-0.00	n/a	n/a
Shareholders Equity	-1.86M	-406.69K	3.56M	7.52M	7.28M	16.16M	26.37M	37.15M	49.86M	59.26M	67.32M	86.64M	93M	102.64M	110.72M	117.57M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-564.84K	n/a	n/a	n/a	n/a	n/a	n/a	n/a